Patent Infringement Settlement

RNS Number : 0517S
Medaphor Group PLC
16 December 2016
 

 

MedaPhor Group plc

("the Group" the "Company")

 

Patent Infringement Settlement

 

Further to the statement made by the Company on 27 April 2016 (RNS No. 4638W: Notice of Patent Infringement Proceedings), the Group subsidiaries, MedaPhor Limited and MedaPhor North America Inc. (collectively "MedaPhor"), announce that MedaPhor and SonoSim Inc. and The Regents of the University of California have reached an agreement in principle on a patent license and patent infringement settlement.  As a result, the parties will proceed to formalize their agreement in writing, following which the lawsuit between the parties will be dismissed. 

 

The settlement will be satisfied from the existing cash resources of the Group. The Company will provide a further update on the settlement once all documents are finalised.

 

This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulations which came into effect on 3 July 2016.

 

Enquiries:

 

MedaPhor Group plc

www.medaphor.com

Stuart Gall, CEO

Tel: +44 (0)29 2075 6534

 

 

Cenkos Securities

Tel:  +44 (0)20 7397 8900

Bobbie Hilliam (Nominated Adviser)

 

Julian Morse (Corporate Broking)

 

 

 

Walbrook PR

Tel: +44 (0)20 7933 8780 or medaphor@walbrookpr.com

Paul McManus / Anna Dunphy

Mob: +44 (0)7980 541 893 / Mob: +44 (0)7876 741 001

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGGPPPUPQUMQ
UK 100

Latest directors dealings